Effects of folic acid on renal endothelial function in patients with diabetic nephropathy: Results from a randomized trial

Clinical Science

Volumn 127, Issue 7, 2014, Pages 499-505

  Schneider, Markus P ^a   Schneider, Andreas ^b   Jumar, Agnes ^a   Kistner, Iris ^a   Ott, Christian ^a   Schmieder, Roland E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Circulation; Complications; Diabetes mellitus; Endothelium; Folic acid; Nitric oxide

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ASCORBIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOLIC ACID; GLUTATHIONE; GLUTATHIONE DISULFIDE; N(G) METHYLARGININE; NITRIC OXIDE; PLACEBO;

ADULT; ALBUMINURIA; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; ENDOTHELIAL DYSFUNCTION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY PLASMA FLOW; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

AGED; ALBUMINURIA; DIABETIC NEPHROPATHIES; DOUBLE-BLIND METHOD; FOLIC ACID; HUMANS; KIDNEY; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; REGIONAL BLOOD FLOW;

EID: 84903976239     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20140111     Document Type: Article

References (29)

1. de Zeeuw, D., Akizawa, T., Audhya, P., Bakris, G. L., Chin, M., Christ-Schmidt, H., Goldsberry, A., Houser, M., Krauth, M., Lambers Heerspink, H. J. et al. (2013) Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N. Engl. J. Med. 369, 2492-2503
2. Satoh, M., Fujimoto, S., Haruna, Y., Arakawa, S., Horike, H., Komai, N., Sasaki, T., Tsujioka, K., Makino, H. and Kashihara, N. (2005) NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am. J. Physiol. Renal Physiol. 288, F1144-F1152
3. Yuen, D. A., Stead, B. E., Zhang, Y., White, K. E., Kabir, M. G., Thai, K., Advani, S. L., Connelly, K. A., Takano, T., Zhu, L. et al. (2012) eNOS deficiency predisposes podocytes to injury in diabetes. J. Am. Soc. Nephrol. 23, 1810-1823
4. Stroes, E. S., van Faassen, E. E., Yo, M., Martasek, P., Boer, P., Govers, R. and Rabelink, T. J. (2000) Folic acid reverts dysfunction of endothelial nitric oxide synthase. Circ. Res. 86, 1129-1134
5. Gao, L., Chalupsky, K., Stefani, E. and Cai, H. (2009) Mechanistic insights into folic acid-dependent vascular protection: dihydrofolate reductase (DHFR)-mediated reduction in oxidant stress in endothelial cells and angiotensin II-infused mice: a novel HPLC-based fluorescent assay for DHFR activity. J. Mol. Cell. Cardiol. 47, 752-760
6. Cheng, H., Wang, H., Fan, X., Paueksakon, P. and Harris, R. C. (2012) Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice. Kidney Int. 82, 1176-1183
7. Delles, C., Schneider, M. P., Oehmer, S., Fleischmann, I., Fleischmann, E. F. and Schmieder, R. E. (2004) Increased response of renal perfusion to the antioxidant vitamin C in type 2 diabetes. Nephrol. Dial. Transplant. 19, 2513-2518
8. Ritt, M., Ott, C., Raff, U., Schneider, M. P., Schuster, I., Hilgers, K. F., Schlaich, M. P. and Schmieder, R. E. (2009) Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus. Am. J. Kidney Dis. 53, 281-289
9. Schmieder, R. E., Delles, C., Mimran, A., Fauvel, J. P. and Ruilope, L. M. (2007) Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes. Diabetes Care 30, 1351-1356
10. Schaufele, T. G., Schlaich, M. P., Delles, C., Klingbeil, A. U., Fleischmann, E. H. and Schmieder, R. E. (2006) Impaired basal NO activity in patients with glomerular disease and the influence of oxidative stress. Kidney Int. 70, 1177-1181
11. Ott, C., Schneider, M. P., Delles, C., Schlaich, M. P. and Schmieder, R. E. (2011) Reduction in basal nitric oxide activity causes albuminuria. Diabetes 60, 572-576
12. Pena, A. S., Wiltshire, E., Gent, R., Hirte, C. and Couper, J. (2004) Folic acid improves endothelial function in children and adolescents with type 1 diabetes. J. Pediatr. 144, 500-504
13. Delles, C., Jacobi, J., Schlaich, M. P., John, S. and Schmieder, R. E. (2002) Assessment of endothelial function of the renal vasculature in human subjects. Am. J. Hypertens. 15, 3-9
14. Schneider, M. P., Ott, C., Schmidt, S., Kistner, I., Friedrich, S. and Schmieder, R. E. (2013) Poor glycemic control is related to increased nitric oxide activity within the renal circulation of patients with type 2 diabetes. Diabetes Care 36, 4071-4075
15. Schneider, M. P., Schlaich, M. P., Harazny, J. M., Raff, U., Ritt, M., Ott, C. and Schmieder, R. E. (2011) Folic acid treatment normalizes NOS-dependence of vascular tone in the metabolic syndrome. Obesity 19, 960-967
16. Delles, C., Schneider, M. P., Oehmer, S., Fleischmann, E. H. and Schmieder, R. E. (2003) L-arginine-induced vasodilation of the renal vasculature is not altered in hypertensive patients with type 2 diabetes. Diabetes Care 26, 1836-1840
17. Schneider, M. P., Klingbeil, A. U., Delles, C., Schmidt, B. M., John, S. and Schmieder, R. E. (2003) Vitamin C augments the renal response to L-arginine in smokers. Nephrol. Dial. Transplant. 18, 1512-1517
18. Smith, H. W., Finkelstein, N., Aliminosa, L., Crawford, B. and Graber, M. (1945) The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man. J. Clin. Invest. 24, 388-404
19. Youn, J. Y., Gao, L. and Cai, H. (2012) The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes. Diabetologia 55, 2069-2079
20. Sedeek, M., Callera, G., Montezano, A., Gutsol, A., Heitz, F., Szyndralewiez, C., Page, P., Kennedy, C. R., Burns, K. D., Touyz, R. M. and Hebert, R. L. (2010) Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy. Am. J. Physiol. Renal Physiol. 299, F1348-F1358
21. Sukumar, P., Viswambharan, H., Imrie, H., Cubbon, R. M., Yuldasheva, N., Gage, M., Galloway, S., Skromna, A., Kandavelu, P., Santos, C. X. et al. (2013) Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction. Diabetes 62, 2130-2134
22. Cai, S., Khoo, J., Mussa, S., Alp, N. J. and Channon, K. M. (2005) Endothelial nitric oxide synthase dysfunction in diabetic mice: importance of tetrahydrobiopterin in eNOS dimerisation. Diabetologia 48, 1933-1940
23. Taylor, S. Y., Dixon, H. M., Yoganayagam, S., Price, N. and Lang, D. (2013) Folic acid modulates eNOS activity via effects on posttranslational modifications and protein-protein interactions. Eur. J. Pharmacol. 714, 193-201
24. Hwang, S. Y., Siow, Y. L., Au-Yeung, K. K., House, J. and O, K. (2011) Folic acid supplementation inhibits NADPH oxidase-mediated superoxide anion production in the kidney. Am. J. Physiol. Renal. Physiol. 300, F189-F198
25. Bukhari, F. J., Moradi, H., Gollapudi, P., Ju Kim, H., Vaziri, N. D. and Said, H. M. (2011) Effect of chronic kidney disease on the expression of thiamin and folic acid transporters. Nephrol. Dial. Transplant. 26, 2137-2144
26. House, A. A., Eliasziw, M., Cattran, D. C., Churchill, D. N., Oliver, M. J., Fine, A., Dresser, G. K. and Spence, J. D. (2010) Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA 303, 1603-1609
27. Jardine, M. J., Kang, A., Zoungas, S., Navaneethan, S. D., Ninomiya, T., Nigwekar, S. U., Gallagher, M. P., Cass, A., Strippoli, G. and Perkovic, V. (2012) The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis. BMJ 344, e3533
28. Sedeek, M., Gutsol, A., Montezano, A. C., Burger, D., Nguyen Dinh Cat, A., Kennedy, C. R., Burns, K. D., Cooper, M. E., Jandeleit-Dahm, K., Page, P. et al. (2013) Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of type 2 diabetes. Clin. Sci. 124, 191-202
29. Jha, J. C., Gray, S. P., Barit, D., Okabe, J., El-Osta, A., Namikoshi, T., Thallas-Bonke, V., Wingler, K., Szyndralewiez, C., Heitz, F. et al. (2014) Genetic targeting or pharmacologic inhibition of NADPH Oxidase Nox4 provides renoprotection in long-term diabetic nephropathy. J. Am. Soc. Nephrol. 25, 1237-1254